Health claim
“Ozempic may lower the incidence of certain cancers by reducing insulin and IGF‑1 signaling.”
Claim extracted — not yet reviewedHigh riskcancer
This claim has been extracted from the video but has not yet been fully reviewed against published evidence. Treat with appropriate caution.
Evidence Summary
This claim has not yet been reviewed against the literature.
Extracted from
Could Ozempic Help You Live Longer? | Lifespan with Dr. David Sinclair - S2, Ep. 10David Sinclair
The video explores the potential longevity benefits of Ozempic, discussing scientific evidence, mechanisms, and the perspective of Dr. David Sinclair, while emphasizing the need for cautious interpretation of emerging research.
Watch breakdown →